Related Experiment Video
Updated: May 30, 2026
08:34
Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay
Published on: July 15, 2025
Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms
Louise Knudsen1, Pierre De Meyts, Vladislav V Kiselyov
1Department of Insulin and Incretin Biology, Hagedorn Research Institute, Novo Nordisk A/S, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark. lsek@novonordisk.com
The Biochemical Journal
|August 16, 2011
Summary
This study clarifies insulin receptor (IR) isoform binding properties. Insulin binds with higher affinity and faster dissociation to IR-A compared to IR-B, impacting cellular responses.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- The insulin receptor (IR) exists as two main isoforms, IR-A and IR-B, generated by alternative splicing of exon 11.
- Controversies persist regarding the distinct ligand-binding properties and functional implications of IR-A and IR-B.
Purpose of the Study:
- To rigorously re-examine and clarify the ligand-binding characteristics of IR-A and IR-B.
- To investigate the impact of alternative splicing on insulin binding affinity and kinetics.
Main Methods:
- Utilized a novel mathematical analysis based on harmonic oscillator principles.
- Quantified insulin binding affinity, association rates, and dissociation rates for both IR isoforms.
Main Results:
- Insulin demonstrated a 1.5-fold higher apparent affinity for IR-A compared to IR-B.
- IR-A exhibited a 2-fold higher overall dissociation rate and altered rate constants for binding site 1.
- Structural analysis suggests exon 11's proximity to binding site 1 influences these differences.
Conclusions:
- Provides a clear, quantitative distinction in insulin binding between IR-A and IR-B.
- Findings offer a structural basis for the differential ligand-binding properties of insulin receptor isoforms.
- Resolves long-standing debate on IR isoform ligand interactions.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:30Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...